BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 21882013)

  • 1. Microalgae as platforms for production of recombinant proteins and valuable compounds: progress and prospects.
    Gong Y; Hu H; Gao Y; Xu X; Gao H
    J Ind Microbiol Biotechnol; 2011 Dec; 38(12):1879-90. PubMed ID: 21882013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photosynthetic biomanufacturing in green algae; production of recombinant proteins for industrial, nutritional, and medical uses.
    Rasala BA; Mayfield SP
    Photosynth Res; 2015 Mar; 123(3):227-39. PubMed ID: 24659086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Potential for Microalgae as Bioreactors to Produce Pharmaceuticals.
    Yan N; Fan C; Chen Y; Hu Z
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27322258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of recombinant proteins in microalgae at pilot greenhouse scale.
    Gimpel JA; Hyun JS; Schoepp NG; Mayfield SP
    Biotechnol Bioeng; 2015 Feb; 112(2):339-45. PubMed ID: 25116083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlamydomonas reinhardtii as a viable platform for the production of recombinant proteins: current status and perspectives.
    Rosales-Mendoza S; Paz-Maldonado LM; Soria-Guerra RE
    Plant Cell Rep; 2012 Mar; 31(3):479-94. PubMed ID: 22080228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microalgae as bioreactors.
    Walker TL; Purton S; Becker DK; Collet C
    Plant Cell Rep; 2005 Dec; 24(11):629-41. PubMed ID: 16136314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Status and Perspective on the Use of Viral-Based Vectors in Eukaryotic Microalgae.
    Bolaños-Martínez OC; Mahendran G; Rosales-Mendoza S; Vimolmangkang S
    Mar Drugs; 2022 Jun; 20(7):. PubMed ID: 35877728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for high-level recombinant protein expression in transgenic microalgae: a review.
    Potvin G; Zhang Z
    Biotechnol Adv; 2010; 28(6):910-8. PubMed ID: 20728531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspective for the use of genetic transformants in order to enhance the synthesis of the desired metabolites: Engineering chloroplasts of microalgae for the production of bioactive compounds.
    Johanningmeier U; Fischer D
    Adv Exp Med Biol; 2010; 698():144-51. PubMed ID: 21520709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential of transgenic green microalgae; a robust photobioreactor to produce recombinant therapeutic proteins.
    Akbari F; Eskandani M; Khosroushahi AY
    World J Microbiol Biotechnol; 2014 Nov; 30(11):2783-96. PubMed ID: 25115849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of autophagy genes in microalgae: Chlorella as a potential model to study mechanism of autophagy.
    Jiang Q; Zhao L; Dai J; Wu Q
    PLoS One; 2012; 7(7):e41826. PubMed ID: 22848622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Environmental and nuclear influences on microalgal chloroplast gene expression.
    Carrera-Pacheco SE; Hankamer B; Oey M
    Trends Plant Sci; 2023 Aug; 28(8):955-967. PubMed ID: 37080835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient recombinant protein production and secretion from nuclear transgenes in Chlamydomonas reinhardtii.
    Lauersen KJ; Berger H; Mussgnug JH; Kruse O
    J Biotechnol; 2013 Aug; 167(2):101-10. PubMed ID: 23099045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outlook in the application of Chlamydomonas reinhardtii chloroplast as a platform for recombinant protein production.
    Shamriz S; Ofoghi H
    Biotechnol Genet Eng Rev; 2016; 32(1-2):92-106. PubMed ID: 28359189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Micro-algae come of age as a platform for recombinant protein production.
    Specht E; Miyake-Stoner S; Mayfield S
    Biotechnol Lett; 2010 Oct; 32(10):1373-83. PubMed ID: 20556634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The microalga Chlamydomonas reinhardtii as a platform for the production of human protein therapeutics.
    Rasala BA; Mayfield SP
    Bioeng Bugs; 2011; 2(1):50-4. PubMed ID: 21636988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Green biologics: The algal chloroplast as a platform for making biopharmaceuticals.
    Taunt HN; Stoffels L; Purton S
    Bioengineered; 2018 Jan; 9(1):48-54. PubMed ID: 28892417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rapid, modular and marker-free chloroplast expression system for the green alga Chlamydomonas reinhardtii.
    Bertalan I; Munder MC; Weiß C; Kopf J; Fischer D; Johanningmeier U
    J Biotechnol; 2015 Feb; 195():60-6. PubMed ID: 25554634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards developing algal synthetic biology.
    Scaife MA; Smith AG
    Biochem Soc Trans; 2016 Jun; 44(3):716-22. PubMed ID: 27284033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic engineering and synthetic biology strategies for producing high-value natural pigments in Microalgae.
    Cao K; Cui Y; Sun F; Zhang H; Fan J; Ge B; Cao Y; Wang X; Zhu X; Wei Z; Yao Q; Ma J; Wang Y; Meng C; Gao Z
    Biotechnol Adv; 2023 Nov; 68():108236. PubMed ID: 37586543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.